PULSENMORE LTD PLSM
ORD SHS · Common Stock · CUSIP M8S7C5117
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.74.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2026 | 2 |
| Q2 2026 | 3 |
Biggest buyers
| UBS Group AG | Added | +20.7k |
| MCGUIRE CAPITAL ADVISORS INC | New | +500 |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Sonnenschein Elazar 13G · exempt (held before listing) new · filed 2026-04-28 | 28.8% |
| Aquamarine Financial (Cayman) Ltd 13G · institution new · filed 2026-10-08 | 5.0% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Aquamarine Financial (Cayman) Ltd 0.11% of their portfolio | 338.5k $2.0m | Unchanged |
| UBS Group AG 0.00% of their portfolio | 21.0k $111.6k | Added +20.7k |
| MCGUIRE CAPITAL ADVISORS INC 0.00% of their portfolio | 500 $2.7k | New |